Primary Congenital GlaucomaPCGNCT04949555
Long Term Evaluation of Primary Congenital Glaucoma Management in Sohag University Hospital
An observational study of Primary Congenital Glaucoma, run by Sohag University at 1 site in Egypt.
Trial summary
evaluation of primary congenital glaucoma management in sohag university hospital Read more about this study
- Who is it for?
- Ages 3 months and older
- Conditions the study is for
- Primary Congenital Glaucoma
- What is being tested?
- Primary congenital glaucoma evaluation
- How many people
- 150 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2021to 1 Mar 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 months and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: patient s with primary congenital glaucoma operated in sohag university hospital
Who may be able to join
- children operated more than 3 months
Who cannot join
- other types of operated pediatric glaucoma
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Ghada Fathy Mohamed
Sohag
ghada f mohamed, MBBCH, 01004720821 ext. sohag, ghada_fathy_post@med.sohag.edu.eg
ghada f mohamed, MBBCH, 01004620821 ext. sohag, ghada_fathy_post@med.sohag.edu.eg
About this study
Official title: Long Term Evaluation of Primary Congenital Glaucoma Management In Sohag University Hospital
evaluation of primary congenital glaucoma management in sohag university hospital
Read the detailed description
long term evaluation of primary congenital glaucoma management in sohag university hospital
- Conditions
- Primary Congenital Glaucoma
- Being tested
- Primary congenital glaucoma evaluation
- Keywords
- primary congenital glaucoma
- Medical subject headings
- Hydrophthalmos
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Primary congenital glaucoma evaluationOther
long term evaluation of primary congenital glaucoma management
What is being measured
The primary outcome is the main question the study is designed to answer.
evaluation of patient with primary congenital glaucoma managed in sohag university hospital by surgical intervention,trabeculectomy and trabecultomy with mitomycin and ologen.follow up after management by measuring intra ocular pressure by Perkins.
retrospective study
Measured: 3years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jul 2021
- Study start1 Jan 2021
- Primary completion1 Mar 2022 (estimated)
- Study completion1 Mar 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Primary Congenital GlaucomaStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ghada Fathy Mohamed, Sohag University
- Investigators
- ghada f mohamed, MBBCH, Principal investigator, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04949555
- Sponsor's protocol ID
- SohajuGF
- Acronym
- PCG
- Status last verified
- Feb 2022
- First submitted
- 16 Jun 2021
- Last updated
- 9 Feb 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Feb 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Long Term Evaluation of Primary Congenital Glaucoma Management In Sohag University Hospital
- ClinicalTrials.gov ID
- NCT04949555
- Acronym / sponsor ID
- PCG / SohajuGF
- Conditions
- Primary Congenital Glaucoma
- Keywords
- primary congenital glaucoma
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Jan 2021 (actual)
- Primary completion
- 1 Mar 2022 (estimated)
- Study completion
- 1 Mar 2022 (estimated)
- First posted
- 2 Jul 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
evaluation of primary congenital glaucoma management in sohag university hospital
Detailed description
long term evaluation of primary congenital glaucoma management in sohag university hospital
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 3 months and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- patient s with primary congenital glaucoma operated in sohag university hospital
Key inclusion criteria (1 listed)
- children operated more than 3 months
Key exclusion criteria (1 listed)
- other types of operated pediatric glaucoma
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Primary congenital glaucoma evaluationlong term evaluation of primary congenital glaucoma management | Other | – |
Primary outcome
evaluation of patient with primary congenital glaucoma managed in sohag university hospital by surgical intervention,trabeculectomy and trabecultomy with mitomycin and ologen.follow up after management by measuring intra ocular pressure by Perkins.
Time frame: 3years
retrospective study
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Feb 2022.
- Individual participant dataSharing planned: No
Related trials for Primary Congenital Glaucoma
Recruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
Retinitis Pigmentosa (RP), Rod Cone Dystrophy
RecruitingPhase 1/2
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
Primary Open-Angle Glaucoma (POAG)
Not yet recruitingObservational study
Goniotomy in Primary Congenital Glaucoma
Primary Congenital Glaucoma, Goniotomy
Not yet recruiting
Study Aim to Compare the Effect of Different Technique of Airway Managment During Anaesthesia on the Haemodynamics and Intraocular Pressure. Patients Were Divided Into Three Groups of 25 Patients Each. (Group A); Patients Who Were Subjected to LMA Insertion (Group B ).
Congenital Glaucoma
Active, not recruiting
Inverted T Trabeculectomy Primary Congenital Glaucoma
Glaucoma, Congenital, Surgical Treatment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
ghada f mohamed, MBBCH principal investigator
Sohag University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Primary Congenital Glaucoma, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ghada f mohamed, MBBCH (01004720821 ext. sohag, ghada_fathy_post@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
evaluation of patient with primary congenital glaucoma managed in sohag university hospital by surgical intervention,trabeculectomy and trabecultomy with mitomycin and ologen.follow up after management by measuring intra ocular pressure by Perkins. (time frame: 3years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2022.